Christine R. Isabella

Christine R. Isabella

Auto-generated profile, based on publicly available information

Christine R. Isabella

Department of Pediatrics, University of Washington, Seattle, Washington, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2015 in Journal of Medical Genetics
Verified
Journal Article
Open access
PDF file
RBR Bachmann-Gagescu
R Bachmann-Gagescu
JDJ C Dempsey
J C Dempsey
IPI G Phelps
I G Phelps
BOB J O'Roak
B J O'Roak
DKD M Knutzen
D M Knutzen
DDD Doherty
D Doherty
Background: Joubert syndrome (JS) is a recessive neurodevelopmental disorder characterised by hypotonia, ataxia, cognitive impairment, abnormal eye movements, respiratory control disturbances and a distinctive mid-hindbrain malformation. JS demonstrates substantial phenotypic variability and genetic heterogeneity. This study provides a comprehensive view of the current genetic basis, phenotypic range and gene–phenotype associations in JS. Methods: We sequenced 27 JS-associated genes in 440 affected individuals (375 families) from a cohort of 532 individuals (440 families) with JS, using molecular inversion probe-based targeted capture and next-generation sequencing. Variant pathogenicity was defined using the Combined Annotation Dependent Depletion algorithm with an optimised score cut-off. Results: We identified presumed causal variants in 62% of pedigrees, including the first B9D2 mutations associated with JS. 253 different mutations in 23 genes highlight the extreme genetic heterogeneity of JS. Phenotypic analysis revealed that only 34% of individuals have a ‘pure JS’ phenotype. Retinal disease is present in 30% of individuals, renal disease in 25%, coloboma in 17%, polydactyly in 15%, liver fibrosis in 14% and encephalocele in 8%. Loss of CEP290 function is associated with retinal dystrophy, while loss of TMEM67 function is associated with liver fibrosis and coloboma, but we observe no clear-cut distinction between JS subtypes. Conclusions: This work illustrates how combining advanced sequencing techniques with phenotypic data addresses extreme genetic heterogeneity to provide diagnostic and carrier testing, guide medical monitoring for progressive complications, facilitate interpretation of genome-wide sequencing results in individuals with a variety of phenotypes and enable gene-specific treatments in the future.

1 January 2014 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
KTKarina Tuz
Karina Tuz
RBRuxandra Bachmann-Gagescu
Ruxandra Bachmann-Gagescu
DODiana R. O’dAy
Diana R. O’dAy
KHKiet Hua
Kiet Hua
CIChristine R. Isabella
Christine R. Isabella
RFRussell J. Ferland
Russell J. Ferland

24 January 2020 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
CMCaitlin M. McMahon
Caitlin M. McMahon
CIChristine R. Isabella
Christine R. Isabella
IWIan W. Windsor
Ian W. Windsor
PKPaul Kosma
Paul Kosma
RRRonald T. Raines
Ronald T. Raines
LKLaura L. Kiessling
Laura L. Kiessling

21 October 2015 in Journal of Medical Genetics
Verified
Journal Article
Open access
PDF file
GSGisela G Slaats
Gisela G Slaats
CIChristine R Isabella
Christine R Isabella
HKHester Y Kroes
Hester Y Kroes
JDJennifer C Dempsey
Jennifer C Dempsey
HGHendrik Gremmels
Hendrik Gremmels
DDDan Doherty
Dan Doherty
Background: Joubert syndrome (JS) is a recessive ciliopathy characterised by a distinctive brain malformation ‘the molar tooth sign’. Mutations in >27 genes cause JS, and mutations in 12 of these genes also cause Meckel-Gruber syndrome (MKS). The goals of this work are to describe the clinical features of MKS1-related JS and determine whether disease causing MKS1 mutations affect cellular phenotypes such as cilium number, length and protein content as potential mechanisms underlying JS. Methods: We measured cilium number, length and protein content (ARL13B and INPP5E) by immunofluorescence in fibroblasts from individuals with MKS1-related JS and in a three-dimensional (3D) spheroid rescue assay to test the effects of disease-related MKS1 mutations. Results: We report MKS1 mutations (eight of them previously unreported) in nine individuals with JS. A minority of the individuals with MKS1-related JS have MKS features. In contrast to the truncating mutations associated with MKS, all of the individuals with MKS1-related JS carry ≥1 non-truncating mutation. Fibroblasts from individuals with MKS1-related JS make normal or fewer cilia than control fibroblasts, their cilia are more variable in length than controls, and show decreased ciliary ARL13B and INPP5E. Additionally, MKS1 mutant alleles have similar effects in 3D spheroids. Conclusions: MKS1 functions in the transition zone at the base of the cilium to regulate ciliary INPP5E content, through an ARL13B-dependent mechanism. Mutations in INPP5E also cause JS, so our findings in patient fibroblasts support the notion that loss of INPP5E function, due to either mutation or mislocalisation, is a key mechanism underlying JS, downstream of MKS1 and ARL13B.

28 July 2023 in Science Advances
Verified
Journal Article
Open access
RMRobert L. McPherson
Robert L. McPherson
CIChristine R. Isabella
Christine R. Isabella
RWRebecca L. Walker
Rebecca L. Walker
DSDallis Sergio
Dallis Sergio
SBSunhee Bae
Sunhee Bae
LKLaura L. Kiessling
Laura L. Kiessling
Soluble human lectins are critical components of innate immunity. Genetic models suggest that lectins influence host-resident microbiota, but their specificity for commensal and mutualist species is understudied. Elucidating lectins’ roles in regulating microbiota requires an understanding of which microbial species they bind within native communities. To profile human lectin recognition, we developed Lectin-Seq. We apply Lectin-Seq to human fecal microbiota using the soluble mannose-binding lectin (MBL) and intelectin-1 (hItln1). Although each lectin binds a substantial percentage of the samples (10 to 20%), the microbial interactomes of MBL and hItln1 differ markedly in composition and diversity. MBL binding is highly selective for a small subset of species commonly associated with humans. In contrast, hItln1’s interaction profile encompasses a broad range of lower-abundance species. Our data uncover stark differences in the commensal recognition properties of human lectins.

1 February 2018 in Genetics in Medicine
Verified
Journal Article
Closed access
PDF file
IPIan G. Phelps
Ian G. Phelps
JDJennifer C. Dempsey
Jennifer C. Dempsey
MGMegan E. Grout
Megan E. Grout
CIChristine R. Isabella
Christine R. Isabella
HTHannah M. Tully
Hannah M. Tully
RBRuxandra Bachmann-Gagescu
Ruxandra Bachmann-Gagescu